Bill Sibold, Madrigal Pharmaceuticals CEO , joins 'Fast Money' to talk quarterly results.

Madrigal Pharmaceuticals' Rezdiffra had a strong launch with $103.3M in Q4 sales and solid liquidity. See why I have a ...

From STAT’s Matthew Herper: Eikon Therapeutics, the cell-biology-focused startup run by former Merck R&D head Roger ...

Welcome to Madrigal Pharmaceuticals' Fourth Quarter ... it's easy to take, it works fast, and the results that we're seeing in the real world are extremely promising. So, what we believe is ...

Madrigal Pharmaceuticals MDGL reported fourth ... This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting ...

Dave Racaniello is entering his 25th year as New York’s bullpen catcher thanks to a chance meeting with Bobby Valentine.

Three Minnesota Twins players were shaken up after narrowly avoiding a car crash Thursday a few minutes from the club's ...

Despite the Mets' turnaround that coincided with Iglesias' May 31 call-up, teams are not paying players for their locker-room presence. Iglesias, while still very quick, is 35 years old, an age that ...

Nick Madrigal's shoulder injury will require surgery and he will likely miss the entire season. Read more at MLB Trade Rumors ...

New York Mets infielder Nick Madrigal could miss the entire 2025 season with a fractured left shoulder. Manager Carlos ...